Searchable abstracts of presentations at key conferences in endocrinology

ea0020p441 | Obesity and Metabolism | ECE2009

Acute inflammatory biomarker modifications as a result of a single session of submaximal exercises in obese subjects

Caparevic Zorica

Background: Classical risk factors are not capable to explain all the cardiovascular events and new markers are being evaluated to predict events.Aims: We examined the effects of a single session of submaximal exercise (cardiopulmonary exercise cycle ergometer test) on atherogenic lipids in obese subjects focusing on inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP), and oxidized low-density-lipoproteins (oxLDL) as a marker of oxidative...

ea0020p11 | Adrenal | ECE2009

Are there some alterations of salivary cortisol dynamics in obese patients?

Jelic Svetlana , Caparevic Zorica , Ilic Sanja , Marina Djordje

The metabolic syndrome resembles Cushing’s syndrome in several clinical aspects. Main characteristic of both syndromes is obesity assessed by the body mass index (BMI) or waist circumference (WC).The aim of this study was to investigate cortisol dynamics in 20 healthy volunteers (BMI<27 kg/m2; 13 females, 7 males, age 42.1+12.39 years) and 20 obese patients (BMI≥27 kg/m2; 13 females, 7 males, age 49.25+1...

ea0020p381 | Diabetes and Cardiovascular | ECE2009

Plasminogen activator inhibitor 1 and atherosclerosis in diabetes mellitus type 2

Ilic Sanja , Kostic Nada , Caparevic Zorica , Radojkovic Jana , Jelic Svetlana , Marina Djordje

Background and aims: Plasminogen activator inhibitor -1 (PAI-1) increases in diabetes and this might contribute to decreased fibrinolisis and accelerated atherosclerosis. PAI-1 is also contributor to the development of acute myocardial infarction. Measurement of intimal medial thickening (IMT) is indicator of presence and extent of coronary artery disease. Aim of the study was to find association between PAI-1 marker of decreased fibrinolisis and atherosclerosis by measuring I...

ea0020p605 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Hypothalamic–pituitary–adrenal axis in chronic fatigue syndrome

Marina Djordje , Jelic Svetlana , Kostic Nada , Caparevic Zorica , Trbojevic Bozo , Beleslin Biljana , Ilic Sanja , Zarkovic Milos

Background/objectives: The aim of the study was to assess hypothalamic–pituitary–adrenal (HPA) axis in patients with chronic fatigue syndrome (CFS).Design and methods: Twenty-three consecutive patients who fulfilled centers for disease control (CDC) criteria for CFS and twenty healthy controls were included in the study. Low dose ACTH test (1mcg of synthetic adrenocorticotropic hormone Synacthen) and insulin tolerance test (ITT) were done and b...